Partner Therapeutics (PTx) is a leading biotech company dedicated to developing and commercializing innovative therapies to address unmet medical needs. Specializing in oncology, PTx also conducts groundbreaking research in infectious diseases, including advancements in treating COVID-19. With a focus on collaboration and partnership, PTx integrates research, manufacturing, development, and commercialization to swiftly deliver therapies to patients worldwide.

Putting patients first, PTx prioritizes health challenges and aims to enhance patient health and quality of life. They offer educational resources, support programs, and financial assistance to ensure safe, effective, and affordable treatment access for more patients. Recognizing the importance of stakeholders in healthcare, PTx collaborates with clinicians, medical centers, insurers, regulatory agencies, and policy makers to advance healthcare solutions and elevate patient care standards.

By engaging with diverse stakeholders, PTx drives research and development efforts forward in an ever-evolving healthcare landscape. Partner with PTx for great medicines and great outcomes